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Abstract
The objective of this study was to evaluate the transdermal delivery of indomethacin in vitro and in vivo enhanced by iontophoresis and/or electroporation through several barriers. Excised Wistar rat skin, pig skin, human epidermal membrane and
cellulose membrane were tested for the in vitro indomethacin permeation, whereas drug concentration of in the plasma was
analyzed to monitor the percutaneous absorption in Wistar rat in vivo. Iontophoresis enhanced the in vitro transdermal delivery
of indomethacin as compared to the passive diffusion. Pulsing of high voltages, as known as electroporation, followed by iontophoresis did result in a synergistic effect in contrast to iontophoresis or electroporation alone. The in vitro result indicated that
higher drug permeation could be induced during and after the application of iontophoresis. In some case, the permeation could
benefit from the electroporation in term of cumulative amount within 12 hr. Furthermore, the combination of electroporation and
iontophoresis resulted in a higher permeation amount than iontophoresis or electroporation alone did. Both iontophoresis and
the combination protocol could reduce interspecies difference in vitro. The in vivo results were similar to that of in vitro ones.
Iontophoresis and electroporation/iontophoresis resulted in higher AUC (area under curve) of blood concentration profiles of indomethacin. In addition, the combination protocol significantly induced higher transepidermal water loss (TEWL). It is concluded
that the in vivo permeation results did correspond to the enhancement efficiency of the in vitro experiments.
Key words: transdermal delivery, indomethacin, iontophoresis, electroporation, TEWL

Introduction
The delivery of drugs via skin routes has been studied extensively in the pharmaceutical field. Drug delivery across skin offers the advantages of accessibility,
non-invasiveness, compliance, safety and effectiveness.
Nevertheless, its clinical application has been limited due
to the barrier properties of skin, especially the stratum
corneum (SC). Several strategies have been developed
to overcome the barriers of the SC and to enhance the
transdermal drug delivery(1). Iontophoresis and electroporation belong to the electrically assisted methods that
have been demonstrated as effective means to enhance
transdermal permeation of drugs (2,3). In the iontophoresis, the electrical power of low voltage (typically 10 V or
less) and constant current (typically 0.5 mA/cm 2 or less)
was employed to push charged or uncharged molecules
through skin or other tissues. Electroporation involves
the application of high voltage (typically > 100 V) and
short-duration (µs ~ ms) pulse to increase the permeability of skin (4,5). Electroporation is usually coupled with
* Author for correspondence. Tel: +886-7-3121101 ext. 2166;
Fax: +886-7-3210683; E-mail: yhtsai@kmu.edu.tw

iontophoresis so that transdermal drug delivery is further
facilitated.
Indomethacin is a non-steroidal anti-inf lammatory
drug which can cause considerable gastrointestinal side
effects when administered orally, whereas such side
effects could be reduced when the compound is applied
on skin. A previous study shows that the application
of iontophoresis can elevate the plasma concentration
of indomethacin th rough the t ransder mal routes (6) .
Furthermore, the use of iontophoresis to facilitate the
underlying deep tissue permeation of drugs after topical
administration will be most beneficial in the treatment
of osteoarthritis, soft tissue rheumatism, tendonitis,
and other deep routed local inflammatory conditions (7).
Hence electrically assisted methods may be suitable for
topical delivery of indomethacin to achieve both local
and systemic effects.
The aim of this present study was to investigate
the inf luence of iontophoresis or electroporation on the
transdermal permeation of indomethacin of in vitro and
in vivo. The effect of combined iontophoresis and electroporation combination protocol was also examined.
Various membranes, including cellulose membrane,
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Wistar rat skin, pig skin and human epidermal membrane
(HEM), were used as permeation barriers in the in vitro
study. Wistar rat was used as the animal model in the in
vivo study.

Materials and methods
I. Materials and Skins
Indomethacin was purchased from Sigma Chemical
Co. (MO, USA). The cellulose membrane (Spectra-por ®
2, molecule weight cut-off = 12,000 ~ 14,000) was
supplied by Spectrum Co. (TX, USA). In vitro permeat ion exper i ments were per for med usi ng f ull sk i n
removed from the back region of female Wistar rats (180
~ 200 g) and that of pigs (one-week old). The hair of
the skin was shaved using an electric clipper. Human
skin from breast site was supplied by Chung-Ho Memorial Hospital of Kaohsiung Medical University, and the
epidermal membrane was prepared by heat separation
method (8). All chemicals and solvents used in the study
were of analytical grade.
II. In Vitro Permeation Experiments
The in vitro permeation studies were performed
using horizontal glass diff usion cells. The skin or
membrane was mounted between the two half horizontal
cells. The receptor compartment contained 8 mL of 0.06
M citrate-phosphate buffer, pH 7.4. The donor compartment of the cell was filled with 8 mL of 0.06 M citratephosphate buffer, pH 6.5, containing 12.5 mM indomethacin. The available skin diffusion area was 0.785
cm 2. The cells were maintained at 37°C and agitated by
magnetic stirrers at 600 rpm. Aliquotes (300 µL) were
withdrawn from the receptor compartment at regular
intervals and immediately replaced by an equal volume
of fresh buffer solution. The indomethacin concentration
was then analyzed by HPLC.
III. Iontophoresis and Electroporation Protocols
For the in vitro per meation exper iments under
iontophoresis, a pair of platinum wires (0.5 mm diameter) with an effective length of 15 mm was immersed
in the buffer as electrodes, with cathode in donor site
and anode in receptor site. The electrodes were each
positioned 3 cm away from each side of the skin or
membrane. The electrodes were connected to a direct
current power supply (Yokogawa Electrical Co., Model
7651, Japan). The current density was set at 0.5 mA/cm 2.
The iontophoresis was applied constantly and the application time was set 3 hr.
Electroporation was performed using an exponential
decay pulse generator (BTX Co., ECM 630 Electro Cell
Manipulator, USA). A pair of platinum electrodes (0.5 ×

1.5 cm 2) were located each 3 cm away from the skin or
membrane. The cathode was positioned in the donor site
and the anode in the receptor site unless otherwise noted.
The electroporation protocol was applied for 10 min with
1 pulse per 30 sec; the pulse voltage was 300 V and pulse
duration was about 200 ms. The voltage was expressed as
the applied value but not as the true transdermal value.
The combination protocol was composed of 10 min
of electroporation followed by 3 hr of iontophoresis.
IV. In Vivo Transdermal Study
Female Wistar rat (180 ~ 200 g) was anesthetized
by intraperitoneal injection of 25% urethane at a dose of
3 mL/kg and the back fur was shaved. Two glass cylinders with the available diffusion area of 1.539 cm 2 each
were placed above the dorsal skin with glue (Instant
Super glue ®, Kokuyo Co., Japan). A 2 mL of citratephosphate buffer, pH 6.5, containing 12.5 mM indomethacin was added into the donor cylinder, while the receptor
cylinder was filled with 2 mL of citrate-phosphate buffer,
pH 7.4. The platinum plates were put in the center of the
cylinders and vertical to the skin. The pair of platinum
wires was bent to be horizontal to the skin and parallel to
each other. After the electrical protocol started, about 0.4
mL of blood was withdrawn from the carotid every 1-hr
intervals. The plasma was added with p-phenylphenol
as an internal standard, extracted with dichloromethane,
vacuum-dried and re-dissolved with mobile phase. All
plasma samples were analyzed by HPLC.
V. Sample Preparation and HPLC Analysis of Indomethacin
The in vitro samples of indomethacin were acidified with 1N HCl and added with p-phenylphenol as
internal standard before HPLC analysis. The plasma
samples of in vivo study were added with 1N HCl and
p-phenylphenol, and extracted with dichloromethane.
The organic layer of each sample was, collected, vacuum
vaporized and redissolved with the mobile phase. In
vitro and in vivo samples were analyzed by a modified HPLC method (9). The HPLC system consisting of
a Hitachi L-7100 pump, a Hitachi L-7400 UV detector
and a Hitachi L-7200 sample processor. A C18 column
(LichroCart ® 125-4, Merck) was used. The mobile phase
consisted of 72% methanol and 28% de-ionized water
with 0.05% acetic acid at a flow rate of 1 mL/min. The
wavelength of the UV detector was set at 260 nm.
VI. In Vivo TEWL Evaluation
The method of setting up the glass cylinder and
administrating the buffer containing indomethacin was
the same as that of the in vivo transdermal study. After
3-hr administration, the formulation and buffer were
removed, and the application site was gently cleaned with
a cotton swab and allowed undisturbed for another 3 hr
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VII. Data Analysis
Values of flux at the first 3 hr and the steady state
f lux calculated from the linear portion of the plot of
cumulative amount versus time (6 ~ 12 hr, R 2 > 0.9) were
analyzed. Penetration index (PI) was calculated from
the ratio of cumulative amount of electrically assisted
method to the cumulative amount of passive control.
The Student’s t-test and one-way ANOVA were utilized
to test effects of various treatment effects. Subgroup
comparisons were made using the Newman-Keuls multiple comparisons. The level of significance in all tests
was set at 0.05.

Results and discussion
I. In vitro Permeation Experiments
(I) The Enhancement of Iontophoresis and Electroporation
It has been reported in literatures that iontophoresis with platinum electrode can cause the pH change
of buffer in the in vitro study. In our experiment, this
phenomenon was examined by using diffusion cells
with blank buffers and rat skins as barriers. The result
demonstrated that pH values of both donor and receptor
buffers remained stable even after 24 hr of iontophoresis of 0.5 mA/cm 2 and indicated that platinum electrode
would not affect the result of the study.
The cumulative amounts of indomethacin penetration (nmol/cm 2) through the cellulose membrane with
various methods including iontophoresis, electroporation and combination protocol were plotted against time
as shown in Figure 1. The permeation parameters and
the enhancement PI of each methods are listed in Table
1. The cumulative amount of indomethacin penetration
through cellulose membrane at 12 hr increased in the
order of combination protocol  iontophoresis > electroporation (Newman-Keuls test).
The cumulative amount of indomethacin through
cellulose membrane by iontophoresis at 3 hr or 12 hr is
higher (ANOVA test, p < 0.05) than that by passive diffusion, indicating that the contribution of electrophoretic
drift enhanced by iontophoresis was significant for indomethacin. However, both PI’s of 3 hr and 12 hr by iontophoresis were relatively low in the membrane group. This
may indicate the high porosity of the cellulose membrane,

2000

Cumulative amount (nmol/cm2)

due to the residual solution. TEWL was determined at the
intervals of 6, 12, 24, 26 and 48 hr. TEWL of the donor
and receptor site were measured quantitatively using a
Tewa meter ® 210 (Courage and Khazaka Co., Germany).
Reference site of each rat was chosen close to both donor
and receptor. The TEWL was calculated automatically
and expressed in g/cm 2/hr. An adjacent untreated site was
used as the basal standard for each determination.
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Figure 1. Cumulative amount of indomethacin in citrate-phosphate
buffer, pH 6.5, detected in the receptor phase versus time by
treating electrically assisted methods across cellulose membrane.
All data represent the means of the experiments ± S.D. (n = 4). ITP,
iontophoresis; EP, electroporation.

suggesting that water-filled pores or channels exist for
drug molecules to diffuse freely at certain levels.
The diffusion of indomethacin across cellulose
membrane by electroporation was similar to the control,
as indicated by the 3 hr cumulative amount and 0 ~ 3 hr
flux due to the existing pores of the cellulose membrane
(Figure 1). This result confirmed that the permeationenhancing effects of electroporation were predominantly
attributed to the formation of micropore structures on
the biological skin, and thereby making a permeabilized
skin by the exposure of high-voltage pulses before applying iontophoresis. However, a 12 hr cumulative amount
and steady-state f lux achieved by electroporation were
significantly higher than that of passive control, suggesting that long-term transport could benefit from electroporation. The enhancement mechanism by electroporation is the creation of aqueous pores in lipid bilayers
of mammalian skin (10) , which might significantly but
weakly affect the cellulose membrane in the study. It is
shown in Table 1 that the cumulative amount of cellulose membrane by a combination protocol approximated
to that by iontophoresis alone (Newman-Keuls test, p
> 0.05). The result indicated that the effect of electromotive force on the permeation of indomethacin after
applying electroporation for the first 3 hr was negligible.
Furthermore, the contribution of electroporation was
also limited, which could be seen in results of the 12 hr
cumulative amount and steady-state flux of indomethacin
penetrating through cellulose membrane while applying
electroporation with iontophoresis.
In order to simulate the in vivo transdermal delivery, rat skin was used as the permeation barrier for the
in vitro study. The cumulative amount of indomethacin
(nmol/cm2) in the receptor compartment was a function
of time with or without iontophoresis and electropora-
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Table 1. The in vitro permeation profiles of transdermal indomethacin delivery by electrically-assisted methods across various skins and
cellulose membrane
Skin types

Membrane

Wistar rat

Pig

Human
epidermal
membrane
(HEM)

3 hr C.A.a
(nmol/cm 2)

3 hr PIb

12 hr C.A.
(nmol/cm 2)

12 hr PI

0~3 hr flux
(nmol/cm 2/hr)

Steady-state flux
(nmol/cm 2/hr)

Passive

202.11 ± 13.67α

1.00

890.0 ± 38.53α

1.00

70.68 ± 4.79α

77.62 ± 3.03α

ITPc

353.25 ± 21.31β

1.75

1709.03 ± 102.01β

155.20 ± 10.50β

Modes

d

α

1.92

118.68 ± 6.49β

χ

1.13

72.98 ± 2.16

α

88.94 ± 4.34χ

EP

215.83 ± 8.87

1.07

1002.77 ± 34.60

EP+ITP

360.37 ± 23.86β

1.78

1665.29 ± 61.38β

1.87

121.81 ± 5.88β

146.28 ± 7.17β

Passive

2.00 ± 2.18α

1.00

16.04 ± 11.41α

1.00

0.64 ± 0.56α

1.88 ± 1.26α

6.25

β

6.66 ± 0.20β

1.52 ± 0.32α

6.57 ± 2.59β

χ

18.90 ± 1.90χ

0.87 ± 1.73α

0.68 ± 1.00α

β

3.68 ± 1.78β

2.46

1.31 ± 0.84α

1.18 ± 0.75α

25.74

χ

4.26 ± 1.53β

1.00

0.82 ± 0.41α

1.47 ± 0.64α

7.85

β

3.59 ± 2.35α

ITP
EP

β

26.39 ± 4.97

13.20

4.45 ± 1.11α

2.23
χ

EP+ITP

159.91 ± 24.12

Passive

1.41 ± 2.82α

1.00
β

ITP

29.64 ± 10.27

EP

3.62 ± 2.60α

EP+ITP

70.55 ± 23.29

Passive

1.63 ± 0.91α

ITP

63.56 ± 25.72

EP

12.10 ± 3.26α

EP+ITP

79.80

χ

β

126.21 ± 65.08

57.92 ± 23.85χ
417.45 ± 5.50

δ

81.23 ± 17.22

2.57

15.48 ± 9.28α

1.00
β

50.04

161.62 ± 39.49

1.00

13.64 ± 6.52α

39.00
77.43

3.61
26.03

6.28 ± 8.75α

21.02

7.42
χ

100.22 ± 7.46

β

χ

107.08 ± 46.92

β

52.33 ± 18.21α,β
201.94 ± 86.36

χ

12.93

3.84
13.35

12.17 ± 3.00
54.82 ± 9.38
10.21 ± 4.19
23.23 ± 7.98
21.96 ± 9.21

3.84 ± 1.07α

4.77 ± 1.55α
χ

43.27 ± 23.11

4.68 ± 2.35α

Each value represents the mean ± S.D. (n = 3~5).
α,β,χ,δ
Modes with the same skin type and Latin letter are not significantly different and that with different letters are significantly different
(ANOVA followed by Newman-Keuls test, p < 0.05).
a
C.A.: cumulative amount.
b
Penetration index (PI): cumulative amount of electrically-assisted method/cumulative amount of passive control.
c
ITP: iontophoresis.
d
EP: electroporation.

tion as shown in Figure 2 (A). There was limited passive
permeation (in the absence of electric modulation) of
indomethacin across rat skin during 12 hr. Application
of electrically-assisted methods could greatly enhance
the transdermal permeation of indomethacin. Iontophoresis, 0.5 mA/cm 2 for 3 hr, greatly enhanced the transdermal indomethacin permeation by 6.25 folds increase
in terms of 12 hr cumulative amount as summarized in
Table 1. Cumulative amount at 3hr and flux during the
course of iontophoresis were also significantly increased
(ANOVA test, p < 0.05). Moreover, steady state flux was
significantly higher than control when the current was
ceased (ANOVA test, p < 0.05). The current density was
set at 0.5 mA/cm 2 , which has been reported in the literature to be the maximum acceptable level concerning
the minimal skin damage and irritation(11). Indomethacin is an acidic drug with a pKa of 4.5 and should be
almost completely ionized in the donor solution (pH 6.5).
Therefore the observed enhancement of skin permeation of anionic indomethacin could be attributed to the
electric potential gradient resulted from the application of iontophoresis. Although the current density was
switched off after 3hr, indomethacin molecules continuously permeated across the skin as shown in Figure 2
(A). One explanation is the existence of a drug reservoir

within the skin. In the current-off period, the permeating ions kept released from the skin until the drug reservoir drained off. Another explanation is the alteration
of the nature of skin. The major route of iontophoretic
transport is believed to be appendageal pores including
the sweat ducts and hair follicles (7). A non-appendageal
pore pathway has also been proposed, which probably
implies the current flow through “artificial shunts” as a
result of disruption of the organized structure of SC (4).
The barrier function of the SC will be estimated by
measuring TEWL as described below.
As show n i n the ti me cou rse of i ndomethaci n
permeation across rat skin by electroporation in Figure 2
(A), electroporation had no significant effect on transdermal delivery in the first 3 hr; however, the application of
high voltage pulses significantly boosted the permeation
amount of the drug at 12 hr as compared to the passive
permeation. The results indicated that electroporation could benefit the long-term transdermal transport,
since this phenomenon was also observed with cellulose
membrane. The continuous accumulation of indomethacin post electroporation may indicate the formation of a
drug reservoir or alteration of skin structure.
The increase of molecule transport by electroporation can be attributed to the creation of electropores as
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negative polarity as indicated in Table 1 (t-test, p > 0.05).
This result indicated that the increases of indomethacin
transport were hardly dependent on the pulse polarity,
which suggested that the electrophoresis of electroporation did not significantly contribute to the transport since
the phenomenon should depend on orientation of electrical field.
The enhancement by the combination protocol was
higher than that by individual protocols in terms of
cumulative amount and f lux (Newman-Keuls test, p <
0.05). Moreover, it accumulated 79.8 (3 hr) and 26.03 (12
hr) folds of amounts of passive control, and the cumulative amount was significantly higher than the sum
produced by iontophoresis and by electroporation. The
result suggested that the application of a high voltage
pulse followed by low current density produced synergistic enhancement which was greater than the sum of
individual protocol.
Rat skin is generally considered 2 ~ 5 times more
permeable than human skin in vitro for some drugs,
which hampers the quantitative prediction of cutaneous
drug delivery in humans from rat studies (14). Therefore, the excised pig skin was also used as a diffusion
barrier in the permeation study because of the similarity of human and pig skins. As depicted in Figure 2
(B), the trends of drug permeation by various protocols
were the same for rat skin and pig skin. The passive and
iontophoretic permeation of indomethacin showed no
significant difference (t-test, p > 0.05) between rat and
pig skins (Table 1). On the other hand, the enhancement
of skin permeation by electroporation in pig skin was not
as effective as in rat skin, since electroporation mainly
acts on the skin structure to induce indomethacin permeation, thus indicating more rigid characteristics of pig
skin structure than rat skin.
Iontophoresis and iontophoresis/electroporation
also significantly enhance the 0 ~ 3 hr f lux, 3 hr and
12 hr cumulative amounts of the transdermal transport
of indomethacin through HEM, as shown in Figure 2
(C), although the steady-state f lux among four protocols exhibited no significant difference (ANOVA test,
p > 0.05). Electroporation, however, could not produce
significant enhancement in HEM, which was also found
in pig skin.

200

(II) Inter-species Comparison

Cumulative amount (nmol/cm2)

well as by electrophoresis/iontophoresis due to the localization effect (12). Therefore, in order to elucidate the
inf luence of electroporation/iontophoresis, the polarity
of electrodes was changed. Negative polarity pulsing for
indomethacin may cause structural changes in the skin,
possibly due to electroporation, so that more molecules
move across the skin through both previously existing
and newly created pathways (13). In contrast, positive
polarity pulsing for indomethacin can also create structural changes in the skin, but it has a zero time-integral
of voltage. The positive polarity pulsing of indomethacin produced the total permeated amount of 71.93 ±
14.87 nmol/cm 2 across rat skin for 12 hr, which was
approximate to the value of 57.92 ± 23.85 nmol/cm 2 of
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Figure 2. Cumulative amount of indomethacin from citratephosphate buffer, pH 6.5, detected in the receptor phase versus time
by treating electrically-assisted methods across (A) Wistar rat skin,
(B) pig skin and (C) human epidermal membrane. All data represent
the means of the experiments ± S.D. (n = 3~5). ITP, iontophoresis;
EP, electroporation.

As shown in Table 1, it was noticed that 3-hr PI
of iontophoresis/electroporation of HEM was about 77
folds, which was similar to that of Wistar rat skin and
within the same magnitude order of that of pig skin.
Iontophoresis enhanced the 3-hr cumulative amount
through HEM up to 39 folds, which was about 3 times
of that of Wistar rat skin and 2 times of that of pig skin.
Electroporation was also found to enhance more in HEM
than in Wistar rat skin and pig skin. Most of the 12 hr
PI of the experiments were lower than that of 3-hr PI
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Wistar rat was chosen as an in vivo animal model.
As shown in Figure 3, the AUC under 0 ~ 12 hr of indomethacin by passive, iontophoresis, electroporation and
electroporation/iontophoresis were 0.42 ± 0.51, 12.26
± 1.92, 2.65 ± 1.51 and 17.21 ± 2.07 µg/mL×hr, respectively. The result was similar to that of in vitro study.
In addition, the AUC of first 3hr was linearly associated
with the flux of the first 3hr in vitro (R 2 = 0.88), indicating that AUC proportionally increased as flux increased.
The AUC of indomethacin under 0 ~ 12 hr by electroporation/iontophoresis was higher than that by individual
protocol or passive control (Newman-Keuls test, p <
0.05). The synergistic effect of the combined physical
enhancers could produce about 40-fold AUC of indomethacin by passive transport, suggesting that both in
vitro and in vivo transdermal transport of indomethacin
could benefit more from the combination protocol than
individual protocols.
III. In Vivo TEWL Evaluation
TEWL assay was employed to assess SC damage,
and subsequently the correlation between the damage
to the skin barrier and an increase in TEWL (17). It is
also used to evaluate the post-iontophoresis water loss
from human skin(18). In order to elucidate the safety of
electrically assisted methods on the in vivo permeation
of indomethacin, TEWL values were determined as an
index of skin disruption. Baseline values corresponding to the untreated sites need to be subtracted from
the measurements in order to get the actual changes in
TEWL (ΔTEWL).

3

Concentration (µg/mL)

II. In Vivo Permeation Experiments

At the donor site, iontophoresis and electroporation did not enhance ΔTEWL as compared to the control
group (Figure 4) (Newman-keuls test, p > 0.05). This
may suggest a negligible damage of SC barrier after
iontophoresis and electroporation since skin hydration/
alteration in SC barrier function are responsible for the
increase of ΔTEWL. However, the combination protocol
significantly induced the ΔTEWL values at the donor site
at 12, 24 and 36 hr (Newman-keuls test, p > 0.05). At 48
hr, the ΔTEWL values of all protocols showed no marked
difference. It was also noticed that the ΔTEWL values
of all protocols at 6 hr were high. It might be due to the
vaporization of the residual aqua solution. The results
suggested that the synergistic effect from the combina-
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Figure 3. Indomethacin concentration in male Wistar rat plasma
after treated with electrically assisted methods. All data represent
the means of the experiments ± S.D. (n = 3~5, numbers represent the
means of AUC ± S.D.). ITP, iontophoresis; EP, electroporation.
α,β,χ
Data with the same Latin letter are not significantly different
and that with different letters are significantly different (ANOVA
followed by Newman-Keuls test, p < 0.05).
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since the electrical assistance was ceased after 3 hr. The
results suggested that the combination protocol could
narrow the interspecies difference.
It has been reported that iontophoretic flux measures
were similar when deliver ing lithium ions th rough
human, pig and rabbit skin (15) . Also, iontophoresis
reduced interspecies difference in terms of cumulative
amounts after 2 hr of iontophoresis with 22-hr postiontophoretic passive diffusion and steady-state f lux
with delivery of timolol maleate (16). In our study, it was
found that the 3-hr cumulative amount of passive control,
3-hr cumulative amount of electroporation/iontophoresis, 12-hr cumulative amount of iontophoresis and 12-hr
cumulative amount of electroporation/iontophoresis in
Wistar skin, pig skin or HEM were not significantly
different (ANOVA test, p > 0.05). This suggested that,
not only iontophoresis, electroporation combined with
iontophoresis could reduce the interspecies difference in
terms of 3-hr cumulative amount and that with 9 hr of
post current application, and also produced a synergistic
effect. The results with short-term high voltage pulses
alone varied among different species, however.
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*
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Figure 4. ΔTEWL measured at donor site on male Wistar rat. All
data represent the means of the experiments ± S.D. (n = 3~4). ITP,
iontophoresis; EP, electroporation.
*Significant difference from passive control (ANOVA followed by
Newman-Keuls test, p < 0.05).
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tion, rather than individual protocols, could enhance
the reversible skin hydration and alteration in SC. On
the contrary, all protocols applied did not significantly
increase the ΔTEWL of receptor site (data not shown).
Skin disruption thus occurred only when the combination protocol was applied at the donor site.

Conclusions
The in vitro and in vivo permeation characteristics
of indomethacin by iontophoresis, electroporation, or
a combination of the two, were examined in this study.
Both iontophoresis and electroporation enhanced the in
vitro and in vivo skin permeation of indomethacin. The
in vitro and in vivo enhancement achieved by electroporation was less pronounced than that by iontophoresis.
The combination protocol did further boost the permeated amount of indomethaicn. Iontophoresis and the
combination protocol could reduce interspecies difference in terms of cumulative amounts in vitro. The in
vivo permeation of indomethacin by electrically assisted
methods was quite similar to the in vitro study. The
results of the in vivo permeation study with n animal
model corresponded to that of the in vitro experiment.
While comparing the results of individual protocols and
control, the combination of electroporation and iontophoresis significantly induced higher but reversible transepidermal water loss of the donor site.
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